<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sievers C</submitter><funding>Intramural NIH HHS</funding><funding>National Institute on Deafness and Other Communication Disorders</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>887-902.e5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10175181</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(5)</volume><pubmed_abstract>Neoadjuvant immunotherapies (NITs) have led to clinical benefits in several cancers. Characterization of the molecular mechanisms underlying responses to NIT may lead to improved treatment strategies. Here we show that exhausted, tumor-infiltrating CD8&lt;sup>+&lt;/sup> T (Tex) cells display local and systemic responses to concurrent neoadjuvant TGF-β and PD-L1 blockade. NIT induces a significant and selective increase in circulating Tex cells associated with reduced intratumoral expression of the tissue-retention marker CD103. TGF-β-driven CD103 expression on CD8&lt;sup>+&lt;/sup> T cells is reversed following TGF-β neutralization in vitro, implicating TGF-β in T cell tissue retention and impaired systemic immunity. Transcriptional changes implicate T cell receptor signaling and glutamine metabolism </pubmed_abstract><journal>Cancer cell</journal><pubmed_title>Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer.</pubmed_title><pmcid>PMC10175181</pmcid><funding_grant_id>HHSN261201500003I</funding_grant_id><funding_grant_id>HHSN261201500003C</funding_grant_id><funding_grant_id>ZIA BC012131</funding_grant_id><funding_grant_id>ZIA DC000087</funding_grant_id><pubmed_authors>Chari R</pubmed_authors><pubmed_authors>Redman JM</pubmed_authors><pubmed_authors>Sievers C</pubmed_authors><pubmed_authors>Craveiro M</pubmed_authors><pubmed_authors>Robbins Y</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Soon-Shiong P</pubmed_authors><pubmed_authors>Schlom J</pubmed_authors><pubmed_authors>Gulley J</pubmed_authors><pubmed_authors>Friedman J</pubmed_authors><pubmed_authors>Bai K</pubmed_authors><pubmed_authors>Nguyen A</pubmed_authors><pubmed_authors>Allen CT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer.</name><description>Neoadjuvant immunotherapies (NITs) have led to clinical benefits in several cancers. Characterization of the molecular mechanisms underlying responses to NIT may lead to improved treatment strategies. Here we show that exhausted, tumor-infiltrating CD8&lt;sup>+&lt;/sup> T (Tex) cells display local and systemic responses to concurrent neoadjuvant TGF-β and PD-L1 blockade. NIT induces a significant and selective increase in circulating Tex cells associated with reduced intratumoral expression of the tissue-retention marker CD103. TGF-β-driven CD103 expression on CD8&lt;sup>+&lt;/sup> T cells is reversed following TGF-β neutralization in vitro, implicating TGF-β in T cell tissue retention and impaired systemic immunity. Transcriptional changes implicate T cell receptor signaling and glutamine metabolism </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-06-01T17:26:22.921Z</modification><creation>2026-04-08T14:12:35.988Z</creation></dates><accession>S-EPMC10175181</accession><cross_references><pubmed>37059104</pubmed><doi>10.1016/j.ccell.2023.03.014</doi></cross_references></HashMap>